Mutations and Molecular Diagnostics in Treatment Decisions

Primary myelofibrosis (PMF) is a rare, biologically complex myeloproliferative neoplasm whose course is strongly influenced by molecular, epigenetic, and immunological factors. Advances in genomics, spatial transcriptomics, and targeted therapies have fundamentally transformed diagnosis and treatment in recent years and are increasingly enabling more precise, personalized treatment decisions.